Report cover image

Gingivitis Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385861

Description

Gingivitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gingivitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for gingivitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gingivitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Treatment Type: Medication; Surgical Procedures; Non-Surgical Treatments

2) By Route Of Administration: Oral; Topical

3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies

4) By End-User: Hospitals; Dental Clinics; Homecare Settings

Subsegments:

1) By Medication: Antibiotics; Antiseptic Mouthwashes; Anti-Inflammatory Drugs; Pain Relievers

2) By Surgical Procedures: Flap Surgery; Gingivectomy; Gingivoplasty; Laser Therapy

3) By Non-Surgical Treatments: Scaling and Root Planing; Professional Dental Cleaning; Local Drug Delivery; Lifestyle and Dietary Modifications

Companies Mentioned: Procter & Gamble; Mayo Clinic; British United Provident Association Limited; Colgate-Palmolive Company; Haleon group; Bausch Health Companies Inc.; American Dental Association; Kivonyx Healthcare Pvt Ltd.; ICPA Health Products Limited; Alarsin Pharmaceuticals; Laboratorios KIN; Ikon remedies pvt ltd.; SingleCare Services LLC; Dentulu Inc.; Focus Dental Care; Perio Protect LLC; Algen Healthcare Ltd; Neuracle Lifesciences Private Limited; Dental Herb Company; Shreeji Pharma International.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Dysthymia Market Characteristics
3. Dysthymia Market Trends And Strategies
4. Dysthymia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Dysthymia Growth Analysis And Strategic Analysis Framework
5.1. Global Dysthymia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Dysthymia Market Growth Rate Analysis
5.4. Global Dysthymia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Dysthymia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Dysthymia Total Addressable Market (TAM)
6. Dysthymia Market Segmentation
6.1. Global Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Psychotherapy
Pharmacotherapy
Combination Of Psychotherapy And Pharmacotherapy
6.2. Global Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild
Moderate
Severe
6.3. Global Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anxiety Disorders
Depression
Substance Abuse
6.4. Global Dysthymia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online
Offline
6.5. Global Dysthymia Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
6.6. Global Dysthymia Market, Sub-Segmentation Of Psychotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cognitive Behavioral Therapy (CBT)
Interpersonal Therapy (IPT)
Psychodynamic Therapy
6.7. Global Dysthymia Market, Sub-Segmentation Of Pharmacotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antidepressants (SSRIs, SNRIs, Tricyclic Antidepressants)
Antipsychotics
Mood Stabilizers
6.8. Global Dysthymia Market, Sub-Segmentation Of Combination of Psychotherapy and Pharmacotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cognitive Behavioral Therapy (CBT) with Antidepressants
Interpersonal Therapy (IPT) with Antipsychotics
Psychodynamic Therapy with Mood Stabilizers
7. Dysthymia Market Regional And Country Analysis
7.1. Global Dysthymia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Dysthymia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Dysthymia Market
8.1. Asia-Pacific Dysthymia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Dysthymia Market
9.1. China Dysthymia Market Overview
9.2. China Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Dysthymia Market
10.1. India Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Dysthymia Market
11.1. Japan Dysthymia Market Overview
11.2. Japan Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Dysthymia Market
12.1. Australia Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Dysthymia Market
13.1. Indonesia Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Dysthymia Market
14.1. South Korea Dysthymia Market Overview
14.2. South Korea Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Dysthymia Market
15.1. Western Europe Dysthymia Market Overview
15.2. Western Europe Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Dysthymia Market
16.1. UK Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Dysthymia Market
17.1. Germany Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Dysthymia Market
18.1. France Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Dysthymia Market
19.1. Italy Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Dysthymia Market
20.1. Spain Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Dysthymia Market
21.1. Eastern Europe Dysthymia Market Overview
21.2. Eastern Europe Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Dysthymia Market
22.1. Russia Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Dysthymia Market
23.1. North America Dysthymia Market Overview
23.2. North America Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Dysthymia Market
24.1. USA Dysthymia Market Overview
24.2. USA Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Dysthymia Market
25.1. Canada Dysthymia Market Overview
25.2. Canada Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Dysthymia Market
26.1. South America Dysthymia Market Overview
26.2. South America Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Dysthymia Market
27.1. Brazil Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Dysthymia Market
28.1. Middle East Dysthymia Market Overview
28.2. Middle East Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Dysthymia Market
29.1. Africa Dysthymia Market Overview
29.2. Africa Dysthymia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Dysthymia Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Dysthymia Market, Segmentation By Comorbidities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Dysthymia Market Competitive Landscape And Company Profiles
30.1. Dysthymia Market Competitive Landscape
30.2. Dysthymia Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
31. Dysthymia Market Other Major And Innovative Companies
31.1. BristolMyers Squibb Company
31.2. AstraZeneca plc
31.3. Novartis International AG
31.4. Roche Holding AG
31.5. Takeda Pharmaceutical Company Limited
31.6. Eli Lilly and Company
31.7. Teva Pharmaceutical Industries Ltd.
31.8. Biogen Inc.
31.9. Horizon Therapeutics plc
31.10. Shionogi & Co. Ltd.
31.11. Jazz Pharmaceuticals
31.12. Ipsen SA
31.13. Cipla Limited
31.14. Lupin Pharmaceuticals
31.15. Mallinckrodt Pharmaceuticals
32. Global Dysthymia Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Dysthymia Market
34. Recent Developments In The Dysthymia Market
35. Dysthymia Market High Potential Countries, Segments and Strategies
35.1 Dysthymia Market In 2029 - Countries Offering Most New Opportunities
35.2 Dysthymia Market In 2029 - Segments Offering Most New Opportunities
35.3 Dysthymia Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.